21 February 2022: Clinical Research
Effect of Shengbai Decoction on Chemotherapy-Induced Myelosuppression and Survival of Gastric Cancer Patients After Radical Resection: A Retrospective Study
Linhua Yao 1ABCEF , Wenming Feng 2ABEF , Yulong Tao 2ABCEF , Chengwu Tang 2ABCDEF*DOI: 10.12659/MSM.935936
Med Sci Monit 2022; 28:e935936
Figure 1 Comparison of 3-year recurrence-free survival between the 2 groups. Recurrence was reported in 30 patients (20 from the control group and 10 from the SD group) within the first 3 postoperative years. The SD group had a significantly better 3-year recurrence-free survival than the control group [P=0.0369; hazard ratio (HR) for recurrence, 0.4570; 95% confidence interval (CI), 0.2232 to 0.9355]. MedCalc software (version 15.2.2, MedCalc Software Ltd.) was used to create the figure.